Health care companies by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Hims & Hers Health leads the 170 health care companies ranked by short interest, at 22.0%, ahead of Scholar Rock Holding (19.2%) and TG Therapeutics (19.0%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
170
First
Hims & Hers Health22.0%
Median
4.50%
Combined market value
£6.81T
Countries
14

Market values as of .

All countries
Health Care
All categories
GBP
Clear filters
Health care companies by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Hims & Hers HealthHIMS · Health Care22.0%£2.9B£12.49 3.93% down 49% down United States
2Scholar Rock HoldingSRRK · Health Care19.2%£4.6B£37.79 3.27% up 26% up United States
3TG TherapeuticsTGTX · Health Care19.0%£7.7B£50.63 0.44% up 117% up United States
4GRAILGRAL · Health Care17.8%£3.7B£82.71 6.25% up 19% up United States
5CRISPR TherapeuticsCRSP · Health Care17.7%£3B£30.99 1.12% up 18% down Switzerland
6Rhythm PharmaceuticalsRYTM · Health Care16.8%£6.2B£88.86 2.09% down 18% up United States
7Dianthus TherapeuticsDNTH · Health Care16.5%£3.7B£64.94 1.42% up 108% up United States
8Protagonist TherapeuticsPTGX · Health Care15.7%£6.3B£96.45 0.52% down 51% up United States
9Praxis Precision MedicinesPRAX · Health Care15.1%£6.8B£243.02 4.44% up 86% up United States
10Twist BioscienceTWST · Health Care14.4%£6.3B£91.93 3.63% up 346% up United States
11CytokineticsCYTK · Health Care12.9%£5.4B£38.88 0.62% down 19% down United States
12Ionis PharmaceuticalsIONS · Health Care12.7%£3.4B£20.57 1.48% down 63% down United States
13Kodiak SciencesKOD · Health Care12.4%£4.8B£73.73 1.13% down 399% up United States
14Ligand PharmaceuticalsLGND · Health Care12.3%£4.4B£222.36 2.37% down 50% up United States
15Spyre TherapeuticsSYRE · Health Care12.2%£7.2B£75.59 2.29% down 332% up United States
16Halozyme TherapeuticsHALO · Health Care12.0%£8B£70.38 3.65% down 39% up United States
17ImmunityBioIBRX · Health Care11.9%£5.3B£4.99 2.39% down 232% up United States
18AlkermesALKS · Health Care11.7%£5.9B£35.32 1.12% down 66% up Ireland
19Edgewise TherapeuticsEWTX · Health Care11.6%£3.4B£31.09 1.44% down 86% up United States
20LivaNovaLIVN · Health Care11.5%£3.9B£70.92 1.61% down 77% up United Kingdom
21RadNetRDNT · Health Care11.3%£4.2B£53.09 3.05% down 9% down United States
22RepligenRGEN · Health Care11.0%£8.5B£133.44 1.36% up 12% up United States
23BridgeBio PharmaBBIO · Health Care10.7%£11.6B£59.75 0.46% up 21% up United States
24ErascaERAS · Health Care10.6%£3.8B£10.74 2.36% up 395% up United States
25ExelixisEXEL · Health Care10.5%£12.2B£49.91 4.14% down 63% up United States
26CG OncologyCGON · Health Care10.3%£5.6B£62.44 2.38% up 97% up United States
27Krystal BiotechKRYS · Health Care10.3%£7B£237.14 1.37% down 54% up United States
28TeleflexTFX · Health Care10.3%£5B£125.12 1.06% down 58% up United States
29Cogent BiosciencesCOGT · Health Care10.0%£3.7B£21.35 0.68% up 20% down United States
30Mirum PharmaceuticalsMIRM · Health Care9.99%£4.7B£71.94 2.02% up 34% up United States
31Travere TherapeuticsTVTX · Health Care9.96%£3.6B£37.79 1.33% down 45% up United States
32Kymera TherapeuticsKYMR · Health Care9.84%£7.7B£90.43 2.09% down 87% up United States
33VaxcytePCVX · Health Care9.70%£7.1B£45.00 0.86% up 23% up United States
34Oruka TherapeuticsORKA · Health Care9.53%£5.1B£74.84 2.53% up 255% up United States
3510x GenomicsTXG · Health Care9.48%£6.1B£46.01 5.73% up 247% up United States
36PTC TherapeuticsPTCT · Health Care9.31%£3.8B£45.82 0.22% down 21% down United States
37Madrigal PharmaceuticalsMDGL · Health Care9.20%£7B£303.27 0.08% down 27% down United States
38Jazz PharmaceuticalsJAZZ · Health Care9.03%£11.8B£183.39 2.92% down 41% up Ireland
39ImmunovantIMVT · Health Care8.96%£5.2B£25.13 0.63% down 46% up United States
40Henry ScheinHSIC · Health Care8.47%£7.1B£64.23 1.69% down 20% up United States
41Corcept TherapeuticsCORT · Health Care8.34%£5.5B£50.12 3.03% down 10% down United States
42ModernaMRNA · Health Care8.20%£60.9B£150.55 0.34% up 780% up United States
43Arrowhead PharmaceuticalsARWR · Health Care8.19%£4.7B£33.15 0.85% up 13% up United States
44DaVitaDVA · Health Care8.17%£7.4B£116.89 5.24% down 40% up United States
45VeradermicsMANE · Health Care8.03%£4B£94.79 0.43% down 231% up United States
46HaemoneticsHAE · Health Care7.90%£4.2B£91.62 2.19% down 64% up United States
47InsuletPODD · Health Care7.68%£7.2B£104.05 2.51% down 55% down United States
48GlaukosGKOS · Health Care7.57%£10.6B£179.17 0.82% up 145% up United States
49ResMedRMD · Health Care7.44%£25.3B£180.13 2.62% down 1% down United States
50BrukerBRKR · Health Care7.37%£7.5B£48.95 1.49% up 44% up United States
51BioMarin PharmaceuticalBMRN · Health Care7.29%£9.3B£47.88 2.23% up 17% up United States
52Globus MedicalGMED · Health Care7.14%£7B£52.78 1.86% down 14% down United States
53Adaptive BiotechnologiesADPT · Health Care7.09%£3.6B£22.13 1.99% up 74% up United States
54Definium TherapeuticsDFTX · Health Care7.02%£3B£21.92 1.27% down 168% up United States
55Guardant HealthGH · Health Care6.97%£15.5B£114.91 3.84% up 45% up United States
56Merit Medical SystemsMMSI · Health Care6.67%£3.9B£64.39 1.72% down 1% up United States
57HealthEquityHQY · Health Care6.62%£6.1B£73.32 1.18% down 3% down United States
58Elanco Animal HealthELAN · Health Care6.59%£10.1B£20.25 0.52% down 26% up United States
59HeartflowHTFL · Health Care6.47%£3B£34.63 1.02% down 66% up United States
60InsmedINSM · Health Care6.42%£23.5B£106.91 17.05% up 40% down United States
61Roivant SciencesROIV · Health Care6.28%£21.8B£30.03 1.68% up 91% up United Kingdom
62Charles River Laboratories InternationalCRL · Health Care6.23%£12.2B£255.30 0.48% up 106% up United States
63BillionToOneBLLN · Health Care6.22%£3.3B£69.37 0.61% down 4% down United States
64Axsome TherapeuticsAXSM · Health Care6.20%£5.4B£101.81 0.35% down 6% down United States
65ChemedCHE · Health Care6.14%£5.4B£416.57 0.07% down 27% up United States
66Legend BiotechLEGN · Health Care6.13%£2.4B£12.28 0.92% down 41% down United States
67PenumbraPEN · Health Care6.10%£9.6B£243.86 0.24% down 15% up United States
68Revolution MedicinesRVMD · Health Care6.05%£26.9B£124.44 2.12% up 129% up United States
69RevvityRVTY · Health Care5.85%£13.2B£118.21 1.71% up 62% up United States
70BrightSpring Health ServicesBTSG · Health Care5.83%£9.8B£49.46 5.08% down 109% up United States
71Align TechnologyALGN · Health Care5.83%£8.7B£122.99 1.62% down 23% up United States
72Neurocrine BiosciencesNBIX · Health Care5.83%£12.2B£120.77 2.74% down 17% up United States
73Molina HealthcareMOH · Health Care5.59%£7.8B£150.11 4.69% down 54% up United States
74Lantheus HoldingsLNTH · Health Care5.57%£5.1B£77.82 0.06% up 90% up United States
75Kiniksa Pharmaceuticals InternationalKNSA · Health Care5.47%£5.7B£72.24 0.32% down 129% up United Kingdom
76Oscar HealthOSCR · Health Care5.39%£6.3B£20.34 3.25% down 112% up United States
77Cooper CompaniesCOO · Health Care5.32%£8.7B£45.64 1.47% down 15% down United States
78IlluminaILMN · Health Care5.31%£24.4B£161.36 0.77% up 76% up United States
79Summit TherapeuticsSMMT · Health Care5.28%£6.4B£8.04 0.48% up 36% down United States
80IncyteINCY · Health Care5.22%£18B£88.22 1.77% down 16% up United States
81Medpace HoldingsMEDP · Health Care4.95%£13.6B£487.01 1.26% down 10% up United States
82Bio-TechneTECH · Health Care4.90%£8.7B£55.43 0.07% down 24% up United States
83ABIVAXABVX · Health Care4.70%£5.6B£64.24 0.51% up 32% down France
84Baxter InternationalBAX · Health Care4.58%£10B£19.34 3.04% down 50% up United States
85Ascendis PharmaASND · Health Care4.57%£13.3B£202.53 1.74% down 29% up Denmark
86Universal Health ServicesUHS · Health Care4.42%£7.7B£134.13 5.45% down 17% down United States
87United TherapeuticsUTHR · Health Care4.31%£18.2B£427.68 2.84% down 22% up United States
88Bio-Rad LaboratoriesBIO · Health Care4.30%£7.8B£288.76 2.31% up 22% up United States
89DexComDXCM · Health Care4.27%£22.9B£61.50 2.25% down 41% up United States
90NateraNTRA · Health Care4.19%£32.9B£227.10 2.89% up 28% up United States
91Zimmer Biomet HoldingsZBH · Health Care4.15%£14.9B£78.54 0.30% down 16% up United States
92ZoetisZTS · Health Care4.12%£25.5B£62.74 3.83% down 26% down United States
93Option Care HealthOPCH · Health Care4.10%£3.6B£24.11 0.27% down 12% up United States
94Alnylam PharmaceuticalsALNY · Health Care4.08%£15.1B£112.42 1.31% down 66% down United States
95GE HealthCare TechnologiesGEHC · Health Care4.04%£28.4B£62.76 1.61% down 12% up United States
96Caris Life SciencesCAI · Health Care4.01%£4.3B£14.87 0.00% 19% down United States
97AvantorAVTR · Health Care3.97%£7.9B£11.64 0.71% down 40% up United States
98AlconALC · Health Care3.84%£27.7B£57.72 0.58% up 0% up Switzerland
99BiogenBIIB · Health Care3.69%£27.7B£187.07 2.41% down 49% up United States
100Encompass HealthEHC · Health Care3.68%£9.8B£99.70 3.09% down 20% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 0.7624 GBP).

Questions and answers

Which health care companies rank first by short interest?

Hims & Hers Health (22.0%), Scholar Rock Holding (19.2%) and TG Therapeutics (19.0%) are the top three of the 170 health care companies ranked by short interest as of the 30 Oct 2026 settlement date.

How many health care companies are in this ranking?

170 are ranked by short interest.

What are these health care companies worth together?

The 170 health care companies ranked by short interest have a combined market value of £6.81T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Health care companies by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.